Financial statements Biomedycyna

Balance sheet of Biomedycyna

Company age:
Age:
12 y. 4 m. 11 d.
Share capital:
Share capital:
50 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of BIOMEDYCYNA

Year
2018
2019
2020
2021
2022
2023
Total assets 227 077,42 333 249,63 448 719,12 496 015,65 528 652,72 572 170,96
A. Fixed assets 31 936,64 13 162,50 43 152,50 34 760,00 54 005,00 33 125,00
B. Current assets 195 140,78 320 087,13 405 566,62 461 255,65 474 647,72 539 045,96
C. Share capital contributions (basic funds) - - - - - -
D. Own shares (stocks) - - - - - -
Total liabilities 227 077,22 333 249,63 448 719,12 496 015,65 528 652,72 572 170,96
A. Equity 130 254,47 216 475,13 309 799,32 349 625,06 339 731,04 397 110,40
B. Liabilities and provisions for liabilities 96 822,75 116 774,50 138 919,80 146 390,59 188 921,68 175 060,56
I. Long-term liabilities - 0,00 0,00 0,00 0,00 0,00
II. Short-term liabilities 96 822,75 114 517,90 136 663,20 145 583,44 188 921,68 175 060,56
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.